日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Functional variants at 1p36.23 confer risk of schizophrenia through modulating RERE

1p36.23 的功能性变异通过调节 RERE 基因表达增加患精神分裂症的风险。

Yixing Liu #,Junyang Wang #,Hong Yang #,Yifan Li,Changgai Mu,Xinglun Dang,Xinran Chen,Danyang Li,Mingna Li,Jiewei Liu,Shiwu Li,Jinfeng Yang,Xi Chen,Chen Zhang,Jin Feng,Xiong-Jian Luo

Silencing of circRERE(4-5) inhibits ONECUT2-mediated tumorigenesis and metastasis in gastric cancer.

circRERE(4-5) 的沉默抑制了 ONECUT2 介导的胃癌肿瘤发生和转移。

Circ-RERE promotes autophagy and immune escape in acute myeloid leukemia involving the miR-128-3p/ZEB1/PD-L1 axis.

Circ-RERE 通过 miR-128-3p/ZEB1/PD-L1 轴促进急性髓系白血病中的自噬和免疫逃逸。

Shi XiaoWei, Wang TianTian, Sha KeYa, Li ShuangYue, Pei RenZhi, Lu Ying

A novel protein cRERE encoded by a circular RNA directly targets ERK signaling to alleviate chemotherapy-induced neuropathic pain.

一种由环状 RNA 编码的新型蛋白质 cRERE 直接靶向 ERK 信号通路,以缓解化疗引起的神经性疼痛。

Zhang Jian-Bo, Zhao Zhong-Bao, Wu Jia-Yan, Duan Yu-Juan, Zhou Da-Qiang, Li Qiong, Ren Xu-Han, Yang Xiao-Hua, Zhao Yu-Ting, Zhao Shu-Quan, Chen Mei-Ying, Zhang Xiang-Zhong, Xin Wen-Jun, Guo Guo-Qing, Xie Jing-Dun, Xu Ting

RERE-AS1 as a regulator of immune modulation and therapeutic response in breast cancer.

RERE-AS1 作为乳腺癌免疫调节和治疗反应的调节因子。

Jiang Shaohui, He Weijie, Li Zhimin, He Haodong, Li Yuehua, Wen Meiling, Zhu Hongbo, Luo Pengfei

Spatiotemporal dynamics of RERE in schizophrenia pathogenesis: insights from multi-omics and single-cell sequencing

精神分裂症发病机制中RERE的时空动态:来自多组学和单细胞测序的启示

Shen, Jing; Xiao, Chenxu

Correction to "Genotype-phenotype correlations in individuals with pathogenic RERE variants"

对“致病性 RERE 变异个体中的基因型-表型相关性”的更正

Expanding the Clinical Spectrum of RERE-Related Disorders: A Case Report of Neurodevelopmental Disorder with Brain Malformations Including Chiari Type I

拓展 RERE 相关疾病的临床谱:一例伴有脑畸形(包括 I 型 Chiari 畸形)的神经发育障碍病例报告

Pachajoa, Harry; Gutierrez-Obando, Angela María; Leal, Andrés Felipe

RERE-AS1 enhances the effect of CDK4/6 inhibitor Ribociclib and suppresses malignant phenotype in breast cancer via MEK/ERK pathway

RERE-AS1通过MEK/ERK通路增强CDK4/6抑制剂瑞博西尼的作用,并抑制乳腺癌的恶性表型。

Huang, Zhidong; Lou, Kaixin; Qi, Mengyang; Wang, Jinhui; Li, Linwei; Sun, Bo; Wang, Chen; Zhou, Xirui; Chen, Debo; Liu, Hong

BiP/GRP78 is a pro-viral factor for diverse dsDNA viruses that promotes the survival and proliferation of cells upon KSHV infection

BiP/GRP78 是多种 dsDNA 病毒的促病毒因子,可促进 KSHV 感染后细胞的存活和增殖

Guillermo Najarro, Kevin Brackett, Hunter Woosley, Leah C Dorman, Vincent Turon-Lagot, Sudip Khadka, Catya Faeldonea, Osvaldo Kevin Moreno, Adriana Ramirez Negron, Christina Love, Ryan Ward, Charles Langelier, Frank McCarthy, Carlos Gonzalez, Joshua E Elias, Brooke M Gardner, Carolina Arias